经颅磁治疗仪治疗急性脑梗死患者的临床效果

Clinical Effect of Transcranial Magnetic Therapeutic Instrument in Treating Patients with Acute Cerebral Infarction

目的:分析经颅磁治疗仪治疗急性脑梗死患者的临床效果。方法:选取2022年8月—2023年8月凯里市第一人民医院收治的急性脑梗死患者64例为研究对象,按随机数字表法分为对照组与分析组,各32例。对照组应用常规药物治疗,分析组在对照组基础上增加经颅磁治疗仪治疗。比较两组美国国立卫生研究院卒中量表(NIHSS)、改良Rankin量表(mRS)评分、标准吞咽功能评定量表(SSA)评分、临床疗效及不良反应。结果:治疗前,两组NIHSS、mRS及SSA评分比较,差异无统计学意义(P>0.05);治疗后,两组NIHSS、mRS及SSA评分均降低,分析组低于对照组,差异有统计学意义(P<0.05)。分析组临床疗效有效率高于对照组,差异有统计学意义(P=0.0024)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:在常规药物基础上增加经颅磁治疗仪治疗急性脑梗死患者,可改善神经功能与吞咽功能,临床疗效突出,安全性好。

Objective:To analyze the clinical effect of transcranial magnetic therapeutic instrument in treating patients with acute cerebral infarction.Methods:Sixty-four patients with acute cerebral infarction admitted to Kaili First People's Hospital from August 2022 to August 2023 were selected as the study subjects,and were divided into the control group and the analysis group according to the method of randomized numerical table,each with thirty-two cases.The control group applied conventional drug treatment,and the analysis group added transcranial magnetic therapeutic instrument treatment on the basis of the control group.The National Institutes of Health Stroke Scale(NIHSS),Modified Rankin Scale(mRS)scores,Standardized Swallowing Assessment Scale(SSA)scores,clinical efficacy and adverse reactions were compared between the two groups.Results:Before treatment,there was no statistically significant difference between the NIHSS,mRS and SSA scores of the two groups(P>0.05);after treatment,the NIHSS,mRS and SSA scores of the two groups were reduced,and the analysis group was lower than the control group,and the difference was statistically significant(P<0.05).The effective rate of clinical efficacy of the analysis group was higher than that of the control group,and the difference was statistically significant(P=0.0024).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Adding transcranial magnetic therapeutic instrument on the basis of conventional drugs to treat patients with acute cerebral infarction can improve neurological function and swallowing function,with outstanding clinical efficacy and good safety.